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~ Cellular Basis for the Festures Electrocsrdlographi¢ 
of the LQT1 Form of the Long QT Syndrome. Effects 
of/3 Adrenerglo Agonlsts, Antagonists and Sodium 
Chennel Blockem on Transmural Dlsperolon of 
Repolarlzation and Tomade8 do Polntes 
W, ShtmJzu. C, Antznlovttch/Mn~ct~/~ Mad/col Research Labo~fo~ Uttc~ 
NY ~350f, USA 
Infrt~l~fton: This study ~xamln0s the csllulnr b~slB for the phenetyplq ap- 
po(trsnce of broad.based T w~vo~, Incm~ed tmnsmural dispersion of rape. 
I~ri;~eflon (TDR) end Tornado de P0lntes (TdP) Induced by Isopmtemnol un. 
der ¢ondlllons mimicking the LQT1 form of th~ congenital tong QT wndmmo, 
The effects p.~drsnergle and tlodl~m ¢l~ennel blockers ~m also oveluoted In 
thl~ model in which the KvLQTf dof0ot iS mimicked using ¢hrom,~nol 293B 
(293B) tO block the slowly epllv~llng delayed regllfl~r ognont, xs. 
Methods ~nd Re~lf~: A tmnsmuml EGG ~nd Imnsmembmne action 
potentials from eplc,~rdlal (epl), M ~nd endo~erdt,I (cede) coils were slmulto. 
neously recorded from ~n orteri~tlly.pedu~ed wedge of canine tefl ventricle, 
~93B, ~n IK~ blocker, dos~.dopendently (1 to 100 ,M) prolonged the QT 
Interval ~nd action petentlr~l duration (APDr~) of the throe cell type~, but 
did not widen the T w~ve, (ncm~e TDR, or Induce TdP, I~oproteronel (18o: 
10 to t00 aM) In the continu!~d pmsenc~ el 21)3B (30 pM) abbreviated the 
APD~ of 0pl ~nd ~ndo coils b~lt n~t that of the M coil, resttltlng in widening 
Of the T w~ve and a dramatic aq¢;nnl.allen 0f TDR, 9pontaneou~ as well 
as programmed ele~tn~PJ stimul~tloo (PES).indtloed TdP was observed only 
after exposure to both P.93B nnd mepmleronol, PropranoloI (0.5 fot  .M) 
prevented the ~ctions of leo to ip~m~o TDR ~nd to induce TdP, Mexllet(no 
(~ to ~O I=M) dose.dependently (tbbrsvI~lod the APD~ of M roils more than 
that of opt and endo sells, th~s diminishing TDR; 10 to 20 .M of mexllallno 
Inhibited the effects el leo to (tugment TDR and to lndl, lco TdP, 
Concluplong: This experimental model of LQT1, the lil~t to be developed, 
(ndle,~lea that (~ deflcter~cy of I~, 81one does net induce TdP, but fh~t the 
~ddlflen of p ~dronergtQ influence predisposes to the development el TdP 
by Inclosing Iron,mural dispelston el mpotnriz~tton, most tlkely as a result 
01 ~ large augmentation of residual IK~ In opl and ondo ceils, but not in M 
cells whom IK~, ts tntrin'¢ltcNly weak, Our data eluoldato the cellular basis 
for the therapeutic aetlon~ el It adrenolglc blockers in LQTt and suggest 
that 8odium channel block with Cla~s IB antlarrhythmtcs may be effecflve 
in ~uppmsslng TdP In LQT1 as they am tn LQT2 and LQT3, as well as in 
acquired (drug.induced) forms of the long QT syndrome. 
11:15 
~ HMG-CoA Reductsse Inhlbltom Reduce Cerebral 
Infarct Size by Upmgulstlng Endothelial Nitric Oxide 
Synthase 
U. Le~fs, M. Endres. P.L. Huang. M.A. Moskowitz, J,K. Liao. Bngham and 
Wom~n.~ Hospital and Herren3 Medical School, Boston, MA, USA 
Endothelial nitric oxide (NO) causes vasedllation and attenuates cerebral 
vasctPar injury, Hypoxta caused by cerebral fschorola, however, can decrease 
endothelial NO synthase (ecNOS) activity, and thus, limit its protective f- 
fects, Recent studies suggest that HMG-CoA reductase inhibltors restore 
ecNOS activity via mechanism independent of cholesterol reduction, In hu- 
man endothelial ceils m vitro, we to!,md that treatment with HMG-CoA reduc- 
taso inhibitors, imvastotin (SIM) and Iovastatln, prevented hypoxia-mediated 
downregulation ofecNOS expression and ~cfivity via mechanism(s) involving 
increased ecNOS mRNA stability but not gene transcdption. To determino 
whether HMG-CoA reductase inhibitors can upregulate ecNOS expression 
m rive. mice were subcutaneously-injecled with SIM (2 mg/kg) for 14 days, 
Blood pressure and cholesterol levels were similar bohveen control and SIM- 
heated mice. but ecNOS mRNA expression and activity in the aorta and 
brain of SIM-treated mice were 2- to 3.fold higher than in controls. To test 
whether this increase in ecNOS activity reduces cerebral inlaret size, cere- 
bral ischemia m mice were produced following 2 h o1 middle cerebral artery 
occlusion, Compared to controls, SIM-treated mice had significantly higher 
ccNOS expression end activity, develop smaller cerebral infarcts (73.8 :~ 8.5 
mm "~ vs, 100,7 -~: 7.3 mm ~, p .~ 0,05), and functionally have less neurolog- 
ical motor deficits (0,8 + 0.2 vs 1.7 ~ 0.2, p < 0,01). In contrast, SIM did 
not decrease cerebral infarct size nor lessen neurological motor def cits n 
mutant mice lack ng ecNO~ gene, These findings indicate that HMG-CoA 
reduclase inhibitors reduce cerebral infarct size via mechanism involving the 
upregulation of ecNOS and s~ggest that these agents may be clinically usefu~ 
in treating non-hypercholesterelemic patients with ischemic strokes, 
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~ Testosterone Increases Coronary Blood Flow in Men 
With Coronary Artery Disease 
C M. Webb, J.G~ McNotlI, P. Collins. Importal College of Science, 
Technology & Medi~lne, NaflonM He~lrf & Lung Insfltllte, LondOn, UK 
The Increased incidence of coronaw artery disease in men compared to 
prem~nopeusel women suggests e o'etdmental l i e  of n'~lo hormones on 
the cardiovascular eymm, however tow plasma testommne I~vols may bQ 
associated with Inclosed risk el coronaly athemsclero~ls, Re,.'.ently testes- 
latona has been shown to hove direct missing effecl~ on ¢orona~/arterlQ~ 
in ~nimalo, in vitro end in vivo, The effect of fe~tommne on the hgm~n 
comnnry elmul~tlon remains unknown, We StUdied thitt~n men (n~n $ 
tiP; ag0d 61 • 11 yearn) with proven ooron~/~rlefy di~eaee. Th W un- 
doP, vont measurement of coronary mlefy diameter nnd ¢oronaw blood 
after Intraeomn~w InfIJsions of wht~o control {0.0t ml 60% ethanol), the 
endolhelium.dependent ves(;~ditator acelytcholine it,6, 16 and 160 i,gh~in) 
before ~nd after Infmt~oronery ~dminiM~tl(m el *at;mooing (~mcentmtm~ 
Of testosterone (10 ~°-10 ~ M), Intr~corona~ (~:]ptef WaS used Io me,- 
sum blood flow v~lo~i~y, and corona~ ~r!e.ry diarfietel w~is measured ~ing 
qu~ntif.ative coronRq/~ngi~gmphy, Coronary flow was cak;ut~ted usmg these. 
meaaumments, Them was e significant dOs~nd~nt  Jocose in coro- 
nary blood flow ~t concentrations tO ~ end !0 ~ M te=oste~ (mean (~% 
CI); 37 (28, 49) ~nd 37 (28, 48) mttmin mspecltvety; p = 0,0,36) compare(t o 
bsseline (32 (~5, 4~ I mlknin), Comnaly blood flow was significantly increased 
by aeetylchotine 10 ~ M and 10 ~ M (65 (47, gl) and 81 (60. !10) mttmin 
speclively; both P .~ O,OOt) compared to vehicle control i35 (~1, 56) ml~m~fl), 
but them w~s no difference in diameter, v~lo¢ity or flow msix~ses be~ 
~fter testoaterene. Voht(;10 control did not chang~ coronan/dials.tel, velo~ty 
or flow compared to b~settno, In conelusmn, 8~ute intracoreea W adminis- 
tration Of testosterone, el physiological cof~':entmtions, increases cometary 
blood flow in men with established coronary artery disease. The mechan ...................~m 
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~ Failure of Pressure Overload Hypertrophy in Go=q 
Overexpmsalng Mice 
Y. Sakata, BD, Heir, S,B. Liggett. RA. Welsh. G.W. Dora, If. OWls~ot 
Carcliol~. y. Depclrtment of Internal I~ttcine. Universily of C~,"~nnah, USA 
Receptor.mediated activation of myoca~iaf Gq signaling ~s postulated as 
a biochemical mechanism transducing pressure overload hypertrophy. The 
specific effects ol Gq activation on the functional and moq:~hologic adap- 
latona re pressure overload are not known, To determine the effects of 
intrinsic myocyte G,vq signaling on the left ventricular hypertrophic response 
to experimental pressure overload, fransgenic mice ovemxpressing G~q 
specifically in the heart (G,Yq-25) and nontransgenic siblings under.eat mi- 
cmeurgicat creation of transverse aortic coaretation and the moq~hometric. 
functional, and molecular characteristics el these pressure overload hearts 
were compared at increasing times following surgeP/, Before aortic band- 
ing, isolated G.q-2S ventricular myocytes exhibited contractile depression 
(depressed +dl/dt and dl/dt) and G~,q-25 hearts showed a pattern of fetal 
gene expression similar to the known characteristics of nontransgenic pres- 
sure overload mice. Three weeks after transverse aortic banding. G~rq.25 
left ventricles hypertrophied to a similar extent (approximately 30% increase) 
as nontransgenics, Hr~v.ever, whereas nontransgenics exhibited concentnc 
left ventricutar emodeling with maintained ejection pcrtermaece (compen- 
sated hypertrophy). Gaq-25 left ventricles developed eccentnc hypertrophy 
and ejection perlormance deteriorated, ultimately resulting in left heart fail- 
ure (decompensated hypertrophy). The signature hypertrophy-associated 
progress of fetal cardiac gene expression observed at baseline in G~q-25 
developed after aortic banding of nontransgenics, but did not significantly 
change in aortic band3d Gcrq-25. Intrinsic cardiac myocyte G~q activation 
stimulates fetal gena expression and depresses cardiac myocyte contrac- 
tility. Superimposition of the hemodynamic Stress of pressure overload on 
G¢~q overexpression stimulates a maladaptive form of eccentric hypertrophy 
which leads to rapid functional deterioration. Therefore, G~q-stimulated car- 
diac hypertrophy is functionally deleterious and compromises the ability of 
tile heart to adapt to increased mechanical oad, 
